Benefit from R&D Credit	9 Months Ended
Sep. 30, 2025
Benefit from Research and Development Credit [Abstract]
Benefit from R&D Credit	8. Benefit from R&D credit An additional $2.6 million was recognized in respect of research and development tax credits in the three months ended September 30, 2025 (three months ended September 30, 2024: $4.5 million). An additional $7.6 million was recognized in respect of research and development tax credits in the nine months ended September 30, 2025 (nine months ended September 30, 2024: $9.7 million). The current asset at September 30, 2025 was $22.2 million, comprised of $7.6 million in respect of research and development activities for the nine months ended September 30, 2025 and $24.4 million in respect of the year ended December 31, 2024. In the nine months ended September 30, 2025, the Group received $11.0 million related to the receipt of the 2023 claim for past research and development tax credits.

Benefit from R&D Credit

9 Months Ended

Sep. 30, 2025

Benefit from Research and Development Credit [Abstract]

8. Benefit from R&D credit

An additional $2.6 million was recognized in respect of research and development tax credits in the three months ended September 30, 2025 (three months ended September 30, 2024: $4.5 million).

An additional $7.6 million was recognized in respect of research and development tax credits in the nine months ended September 30, 2025 (nine months ended September 30, 2024: $9.7 million).

The current asset at September 30, 2025 was $22.2 million, comprised of $7.6 million in respect of research and development activities for the nine months ended September 30, 2025 and $24.4 million in respect of the year ended December 31, 2024. In the nine months ended September 30, 2025, the Group received $11.0 million related to the receipt of the 2023 claim for past research and development tax credits.